Clinical Trials Logo

Clinical Trial Summary

The purpose of this study was to evaluate the overall efficacy and safety of Kaempferia parviflora in overall healthy male human subjects.


Clinical Trial Description

This study was an open label safety and efficacy study. Each subject received a specific dose of a formulation containing Kaempferia parviflora. There would be attempted telephone or e-mail contact in 2 weeks following enrollment.

Participants would undergo assessments of blood tests, vital signs, body weight with completion of questionnaires.

The primary objective was to assess the effect of Kaempferia parviflora on erectile function among overall healthy males age 50 to 70. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03389867
Study type Interventional
Source Supplement Formulators, Inc.
Contact
Status Completed
Phase N/A
Start date June 30, 2014
Completion date March 15, 2016

See also
  Status Clinical Trial Phase
Completed NCT03790995 - Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARP
Recruiting NCT05853822 - FirmTech User Research Trial
Suspended NCT03143790 - Ekstracorporal Shock Wave Therapy as a Treatment for Erectile Dysfunction in Men After Prostatectomy N/A